CCL2 and neoplasm: Wild type TP53 could induce CCL2 production and mediates the activation and recruitment of natural killer (NK) cells to the TME 41, while TP53 mutations were correlated with the immunosuppressive M2 phenotype of tumor associated macrophages (TAMs) 42.